WST
West Pharmaceutical Services Inc
373.60$
-0.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 52.5% | 50.6% | 47.0% | 42.5% | 42.2% | 42.2% | 40.3% | 42.5% | 44.4% | 46.3% | 44.4% | 44.3% | |
| 23.9% | 22.3% | 16.7% | 12.8% | 13.4% | 13.3% | 11.2% | 12.9% | 15.3% | 18.5% | 12.7% | 10.7% | |
| 23.9% | 22.3% | 16.7% | 12.8% | 13.4% | 13.3% | 11.2% | 12.9% | 15.3% | 18.5% | 12.7% | 10.7% | |
| 13.8% | 13.4% | 14.5% | 13.7% | 14.3% | 15.2% | 15.0% | 14.7% | 15.2% | 13.5% | 16.7% | 17.5% | |
| 11.5% | 11.4% | 11.9% | 12.0% | 10.9% | 10.3% | 10.7% | 10.7% | 10.7% | 10.4% | 11.0% | 11.0% | |
| 37.5% | – | – | – | 46.6% | 47.1% | 48.8% | 47.1% | 45.6% | 43.2% | – | – | |
| 2.8% | 2.8% | 3.0% | 3.1% | 3.0% | 2.9% | 3.0% | 2.8% | 2.7% | 2.6% | 2.7% | 2.7% | |
| 0.4% | 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | |
| 23.6% | 24.8% | 25.6% | 26.2% | 25.1% | 26.4% | 25.8% | 25.9% | 25.7% | 25.6% | 27.2% | 26.6% | |
| 14.2% | 17.5% | 18.0% | 18.2% | 14.1% | 15.1% | 14.6% | 15.3% | 15.5% | 15.3% | 16.4% | 15.7% | |
| 1.9% | 4.0% | 4.2% | 4.4% | 0.5% | 0.5% | 0.6% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | |
| 5.9% | 6.3% | 6.7% | 6.1% | 6.1% | 6.6% | 6.3% | 6.0% | 6.2% | 5.9% | 6.1% | 6.2% | |
| 4.1% | 1.9% | 2.0% | 2.1% | 5.5% | 5.6% | 5.6% | 5.1% | 4.9% | 4.7% | 4.9% | 5.0% | |
| 76.4% | 75.2% | 74.4% | 73.8% | 74.9% | 73.6% | 74.2% | 74.1% | 74.3% | 74.4% | 72.8% | 73.4% | |
| 91.0% | 92.0% | 100.6% | 106.6% | 104.9% | 108.6% | 111.4% | 104.7% | 103.8% | 102.5% | 108.9% | 113.4% | |
| 2.0% | 2.0% | 2.1% | 2.1% | 2.0% | 2.0% | 2.0% | 1.8% | 1.8% | 1.7% | 1.8% | 1.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.